3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Plasma Cell Myeloma: new trials by email Literature Review of Plasma Cell Myeloma trials Research Report on Plasma Cell Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients isatuximab SAR650984, carfilzomib, dexamethasone - Plasma Cell Myeloma | Phase 3 | Completed | Sanofi | 302 | 2017-10-25 | 2026-02-09 |
| Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients Isatuximab, Pomalidomide, Dexamethasone - Plasma Cell Myeloma | Phase 3 | Completed | Sanofi | 307 | 2016-12-22 | 2025-01-17 |
| Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer Total-Body Irradiation, Fludarabine Phosphate, Mycophenolate Mofetil - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission | Phase 3 | Completed | Fred Hutchinson Cancer Center | 87 | 2003-10-01 | 2017-05-15 |
Multiple Myeloma (3) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Chronic-Phase (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Myelodysplastic-Myeloproliferative Diseases (1) · Waldenstrom Macroglobulinemia (1)
Blood Protein Disorders (3) · Cardiovascular Diseases (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Hemorrhagic Disorders (3) · Hemostatic Disorders (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Plasma Cell (3) · Paraproteinemias (3) · Vascular Diseases (3) · Bone Marrow Diseases (1)
Dexamethasone (2) · isatuximab (2) · Cyclosporine (1) · Cyclosporins (1) · Mycophenolic Acid (1) · Peripheral Blood Stem Cell Transplantation (1) · Whole-Body Irradiation (1) · carfilzomib (1) · fludarabine phosphate (1) · pomalidomide (1)
Sanofi (2) · Fred Hutchinson Cancer Center (1)
Italy (3) · United States (3) · Australia (2) · Canada (2) · Czechia (2) · France (2) · Germany (2) · Greece (2) · Hungary (2) · Japan (2) · New Zealand (2) · Russia (2) · South Korea (2) · Spain (2) · Turkey (Türkiye) (2)
Brenda Sandmaier (1)
PMID 36108425, PMID 31833394, PMID 32499241, PMID 32586908, PMID 33839618, PMID 34097854, PMID 34800109, PMID 35641409, PMID 36239134, PMID 36372355, PMID 37156782, PMID 37479547, PMID 37584290, PMID 38299578, PMID 38573925, PMID 39067465, PMID 42363804
2016 (1), 2017 (1), P01CA078902 (1), P30CA015704 (1)